Moderately to Severely Active Crohns Disease
2 competing products in clinical development for Moderately to Severely Active Crohns Disease.
Pipeline by Phase
Phase 32
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Afimkibart + Placebo | Chugai Pharmaceutical | Phase 3 | Recruiting | 47 |
| Afimkibart + Placebo | Chugai Pharmaceutical | Phase 3 | Recruiting | 47 |